[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335364-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335364-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dual-locked-fluorescent-probes-for-precise-diagnosis-and-targeted-treatment-of-tumors","Dual-locked fluorescent probes for precise diagnosis and targeted treatment of tumors","","Cancer remains a major global health threat, and high mortality is driven largely by delayed diagnosis and non-specific treatment. Early, accurate detection is difficult because initial molecular changes are subtle and often undetectable. Traditional single-target fluorescent probes may cause false positives and limited specificity by relying on single biomarkers. Dual-locked fluorescent probes improve diagnostic precision by requiring two tumor-associated biomarkers or microenvironmental conditions for activation, enabling reduced non-specific signals. This review covers structures, response mechanisms, biological applications, and future challenges for oncology imaging and targeted therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dual-locked-fluorescent-probes-for-precise-diagnosis-and-targeted-treatment-of-tumors/335364/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dual-locked-fluorescent-probes-for-precise-diagnosis-and-targeted-treatment-of-tumors/335364.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are early and accurate cancer diagnosis still challenging?","Question",{"text":63,"@type":64},"Early molecular changes are subtle and often difficult to detect reliably, making precise discrimination between cancerous and normal cells difficult.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What problem do single-target fluorescent probes face in tumor detection?",{"text":68,"@type":64},"They often rely on single biomarkers, which can lead to false-positive signals and inadequate specificity, and they may miss interconnected molecular events.",{"name":70,"@type":61,"acceptedAnswer":71},"How do dual-locked fluorescent probes improve specificity?",{"text":72,"@type":64},"They require the simultaneous presence of two specific tumor-associated biomarkers or microenvironmental conditions, which reduces non-specific activations typical of single-analyte probes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335364,1791163680,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Heliyon 10 (2024) e38174  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Review article\u003Cbr>Dual-locked fluorescent probes for precise diagnosis and targeted treatment of tumors\u003Cbr>Tang Gao a,1, Can Xiang b,1, Xintao Dingc, Mingxing Xiea,*\u003Cbr>a Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China\u003Cbr>b Department of Scientific Management, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430022, China\u003Cbr>c Department of Biomedical Informatics, Columbia University Graduate School of Arts and Sciences, New York, NY, United States |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Fluorescent probes Dual-stimuli responsive Tumor imaging\u003Cbr>Tumor treatment |  | Cancer continues to pose a significant threat to global health, with its high mortality rates largely attributable to delayed diagnosis and non-specific treatments. Early and accurate diagnosis is crucial, yet it remains challenging due to the subtle and often undetectable early molecular changes. Traditional single-target fluorescent probes often fail to accurately identify cancer cells, relying solely on single biomarkers and consequently leading to high rates of false positives and inadequate specificity. In contrast, dual-locked fluorescent probes represent a breakthrough, designed to enhance diagnostic precision. By requiring the simultaneous presence of two specific tumor-associated biomarkers or microenvironmental conditions, these probes significantly reduce non-specific activations typical of conventional single-analyte probes. This review discusses the structural designs, response mechanisms, and biological applications of dual-locked probes, highlighting their potential in tumor imaging and treatment. Importantly, the review addresses the challenges, and perspectives in this field, offering a comprehensive look at the current state and future potential of dual-locked fluorescent probes in oncology. |\n\n1. Introduction  \nCancer is often associated with high mortality rates and stands as the second leading cause of death globally [1]. This primarily stems from delays in detection and diagnosis, which cause many patients to miss the critical period for effective treatment [2,3]. This high mortality rate significantly impacts global health [4]. However, studies have shown that early detection of cancer at the cellular/molecular level can greatly enhance treatment outcomes. For instance, data from the National Cancer Control Center of the Australian Cancer Council indicate a stark contrast in survival rates based on the stage at which breast cancer is diagnosed: a 100 % one-year survival rate for Stage 1 compared to 69 % for Stage 4 [5]. Thus, improving the accuracy of early cancer diagnosis is crucial. One of the primary challenges in cancer diagnosis is the difficulty in distinguishing cancerous cells from normal ones, especially when no clear pathological structural changes are evident. However, certain cellular alterations-like increased enzyme expression and variations in pH and viscosity-are indicative of cancer [6,7]. Therefore, there is a pressing need to develop technologies capable of  \n* Corresponding author.  \nE-mail address: [xiemx@hust.edu.cn](xiemx@hust.edu.cn) (M. Xie).  \n1 Contributed equally to this work.  \n[https://doi.org/10.1016/j.heliyon.2024.e38174](https://doi.org/10.1016/j.heliyon.2024.e38174)  \nReceived 2 July 2024; Received in revised form 18 September 2024; Accepted 19 September 2024 Available online 19 September 2024  \n2405-8440/© 2024 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license  \n([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \naccurately identifying t","cbCaigiqj2jaCWwW","https://ap.wps.com/l/cbCaigiqj2jaCWwW","pdf",28649820,33,"English","# Introduction\n## The challenge of early cancer detection\n## Fluorescence imaging with fluorescent probes\n## Limits of single-analyte fluorescent probes\n## Rationale for dual-locked fluorescent probes","[{\"question\":\"Why are early and accurate cancer diagnosis still challenging?\",\"answer\":\"Early molecular changes are subtle and often difficult to detect reliably, making precise discrimination between cancerous and normal cells difficult.\"},{\"question\":\"What problem do single-target fluorescent probes face in tumor detection?\",\"answer\":\"They often rely on single biomarkers, which can lead to false-positive signals and inadequate specificity, and they may miss interconnected molecular events.\"},{\"question\":\"How do dual-locked fluorescent probes improve specificity?\",\"answer\":\"They require the simultaneous presence of two specific tumor-associated biomarkers or microenvironmental conditions, which reduces non-specific activations typical of single-analyte probes.\"}]","Dual-locked fluorescent probes for precise diagnosis and targeted treatment of tumors | PDF",1790010692,83]